Navigation Links
Van Andel Research Institute and TGen undertake alliance to promote science and health
Date:2/11/2009

PHOENIX, Ariz. Feb. 11, 2009 The Van Andel Research Institute (VARI) and the Translational Genomics Research Institute (TGen) will forge a strategic alliance that will enable both to maximize their worldwide contributions to science and health.

The non-profit researcher institutes jointly announced today the initiation of an "alliance and affiliation agreement.''

The partnership between Grand Rapids, Mich.-based VARI and Phoenix, Ariz.-based TGen will enable both institutes to speed up their mutual goals of moving research discoveries about cancer and other debilitating medical conditions as quickly as possible from laboratories to patient care.

VARI is the research arm of the Van Andel Institute (VAI), established in 1996 as a philanthropic research and educational organization by the late Jay and Betty Van Andel.

"We are excited to welcome TGen as they combine forces with us in our mission to conquer cancer and human disease,'' said VAI Chairman and CEO David Van Andel. "This alliance demonstrates that VARI and TGen are at the forefront of redefining a borderless, collaborative, national and international scientific community that transcends geographical limitations."

The alliance combines the groundbreaking basic research expertise of VARI with the cutting-edge translational genomics and analysis of TGen.

"Combining many of the scientific, educational, financial and business potentials of TGen and VARI will advance the research of both institutions and enhance the economic development of both Arizona and Western Michigan,'' said Dr. Jeffrey Trent, President and Scientific Director of TGen since its founding in 2002.

"This alliance will elevate both organizations in the world of scientific research," said Dr. Trent, who will retain his roles at TGen, but upon implementation of the agreement also will become President and Research Director of VARI.

Dr. Trent will replace Dr. George Vande Woude, who in 1998 was appointed the founding Director of VARI.

"The search for a new director has ended with the best possible results a renowned, research director in Dr. Trent, who will now lead VARI, and an alliance that strengthens two of the nation's fast-emerging leaders in biomedical research," David Van Andel said.

Dr. Vande Woude, a member of the prestigious National Academy of Sciences, will remain at VARI as head of the Laboratory of Molecular Oncology. Dr. Vande Woude, who held top-level administrative posts at the National Cancer Institute since the early 1980's, will be able to achieve a long-held desire to return to the lab full-time.

"This is a great moment for both Institutions. I have known Dr.Trent professionally for nearly 20 years and have always admired him as one of the nation's leading scientists. One of Dr. Trent's greatest attributes is bringing together researchers from many disciplines to work on problems that will improve human health," Dr. Vande Woude said.

TGen is dedicated to conducting groundbreaking research with life changing results. Research at TGen is focused on helping patients with diseases such as cancer, neurological disorders, diabetes and infectious diseases. TGen, founded in 2002, is on the cutting edge of translational research, in which investigators unravel the genetic basis of complex diseases and medical conditions.

VARI opened its facility in 2000. Its 18 research laboratories are primarily dedicated to molecular cancer research, but it also focuses on conditions such as diabetes, Parkinson disease, osteoporosis, and heart disease. VARI will open a 240,000 square-foot building expansion this fall, which will allow it to broaden its efforts to include additional neurological disorders and chronic illnesses. VARI's primary work has been in basic research looking for what occurs to cause disease in individual cells, and using that information to identify "biomarkers" that can help predict and diagnose diseases, and lead to the development of safer, more effective drugs.

"VARI is on the verge of expanding its already strong basic research programs and implementing further translational research,'' said Dr. Daniel Von Hoff, TGen's Physician-In-Chief and a world-renowned cancer scientist.

"TGen is poised to translate the discoveries generated in laboratories from both organizations into real solutions for patients,'' said Dr. Von Hoff, who also is Chief Scientific Officer of TGen Clinical Research Services at Scottsdale Healthcare. "This is a terrific opportunity to work together and increase our chances for making a difference for our patients.''

Both TGen and VARI are relatively young organizations that have triggered regional growth of the life sciences and biomedical industries in Arizona and Western Michigan.

Both organizations have a strong focus on cancer, collaborations and expansion locally, nationally and internationally.

The "alliance and affiliation agreement'' is expected to become effective July 1, 2009.


'/>"/>

Contact: Steve Yozwiak, TGen Senior Science Writer
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute
Source:Eurekalert

Related biology news :

1. American Society for Microbiology honors Jo Handelsman
2. Research shows skeleton to be endocrine organ
3. Newly created cancer stem cells could aid breast cancer research
4. Dominant cholesterol-metabolism ideas challenged by new research
5. Researchers identify proteins involved in new neurodegenerative syndrome
6. Texas researchers and educators head for Antarctica
7. MGH researchers describe new way to identify, evolve novel enzymes
8. University of Pennsylvania researchers develop formula to gauge risk of disease clusters
9. University of Oregon researcher finds that on waters surface, nitric acid is not so tough
10. U of MN researchers discover noninvasive diagnostic tool for brain diseases
11. U of Minnesota researchers discover noninvasive diagnostic tool for brain diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/21/2016)... VANCOUVER, British Columbia , June 21, 2016 ... been appointed to the new role of principal ... has been named the director of customer development. ... , NuData,s chief technical officer. The moves reflect ... development teams in response to high customer demand ...
(Date:6/15/2016)... , June 15, 2016 ... market report titled "Gesture Recognition Market by Application Market - Global ... 2016 - 2024". According to the report, the  global ... billion in 2015 and is estimated to grow ... 48.56 billion by 2024.  Increasing application ...
(Date:6/7/2016)... 2016  Syngrafii Inc. and San Antonio Credit ... includes integrating Syngrafii,s patented LongPen™ eSignature "Wet" solution ... will result in greater convenience for SACU members ... maintaining existing document workflow and compliance requirements. ... Highlights: ...
Breaking Biology News(10 mins):
(Date:12/2/2016)... Dec. 2, 2016 /PRNewswire/ - bioLytical Laboratories, a world leader in rapid infectious disease ... Kenya,s Pharmaceutical Association members. (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) ... ... , , ... Kenya Pharmaceutical Association (KPA) to introduce the INSTI HIV Self Test to 350 pharmacy ...
(Date:11/30/2016)... announced the appointment of Joshua F. Coleman , M.D., ... Coleman will oversee clinical content development and curation of scientific ... suite empowers molecular pathologists with a seamless workflow for the ... quality control through reporting. ... , , Prior ...
(Date:11/30/2016)... , Nov. 30, 2016 /PRNewswire/ - Portage Biotech Inc. ... Exchange: PBT.U), is excited to announce the formation ... on developing preclinical ophthalmology assets through proof of ... anti-inflammatory created by Portage Pharmaceuticals Limited and being ... ocular surface and anterior segment diseases. This agent ...
(Date:11/30/2016)... 30, 2016  The Allen Institute for Cell ... first publicly available collection of gene edited, fluorescently ... key cellular structures with unprecedented clarity. Distributed through ... tools are a crucial first step toward visualizing ... what makes human cells healthy and what goes ...
Breaking Biology Technology: